LA
Luis Arturo
Drug Research and Development Center: Havana, Cu, Lund University, University of Havana
0000-0001-6904-5854
Employment
-
Drug Research and Development Center: Havana, Cu Researcher2013 - Present
-
Lund University
Education
-
University of Havana Master Degree in Pharmacology2014 - 2015
-
University of Havana Bachelor's at Biochemistry and Molecular Biology2007 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Behavioral tests to assess short- and long-lasting sensorimotor deficits following transient focal cerebral ischemia in rodents Save
- Randomized Controlled Preclinical Trial of a Benzodiazepine–Dihydropyridine Hybrid Molecule in Rodent Stroke Save
- JM-20 administration to animals with lesion of the nigrostriatal dopamine pathway induced by 6-hydroxydopamine, partially reverses motor damage and oxidative stress Save
- JM-20 administration to animals with lesion of the nigrostriatal dopamine pathway induced by 6-hydroxydopamine, partially reverses motor damage and oxidative stress Save
- A randomized, controlled, two-center preclinical trial assessing the efficacy of a new benzodiazepine–dihydropyridine hybrid molecule (JM-20) in rodent models of ischemic stroke Save
- JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats Save
- Novel arylidene malonate derivative, KM-34, showed neuroprotective effects on in vitro and in vivo models of ischemia/reperfusion Save
- JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson’s disease: Mitochondrial protection and antioxidant properties Save
- KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity Save
- JM-20 protects memory acquisition and consolidation on scopolamine model of cognitive impairment Save